US Patent 9321764 Dihydro-pyrrolopyridinone inhibitors
Patent 9321764 was granted and assigned to AbbVie Inc. on April, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+74 characters)
Article
Patent abstract
The present invention provides for compounds of formula (I)
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09321764 Dihydro-pyrrolopyridinone inhibitors US Patent 9321764 Dihydro-pyrrolopyridinone inhibitors
Infobox
Patent Number
0932176400
Patent Number
932176400
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093217640
Date of Patent
April 26, 2016
0Patent Application Number
142060280
Date Filed
March 12, 2014
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093217640
Date of Patent
April 26, 2016
0Patent Application Number
142060280
Date Filed
March 12, 2014
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09321764 Dihydro-pyrrolopyridinone inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09321764
Date of patent
April 26, 2016
Patent application number
14206028
Date Filed
March 12, 2014
Patent primary examiner
Find more entities like US Patent 9321764 Dihydro-pyrrolopyridinone inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
